The CHAMPION-AF trial, sponsored by Boston Scientific, is assessing the WATCHMAN FLX device as an alternative to non-vitamin K oral anticoagulants in patients with non-valvular atrial fibrillation.

ClinicalJuly 6, 2026

Boston Medical Center Study on Ultrasound for Heart Failure Management

A study is underway to evaluate the effectiveness of a novel ultrasound technique in predicting volume overload in heart failure patients.

Upcoming milestones

No catalysts indexed for this entity yet.

Related catalysts

No catalysts indexed for this entity yet.

Indications

No related entities indexed yet.

Therapeutic areas

Atrial Fibrillation →

Cardiology →

Heart Failure →

Newsletter

Get signals before the market moves

Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.

No paywall. No spam. Unsubscribe anytime.